Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hanlon

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Breast Cancer (Dove Medical Press)|May 18, 2016
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependentKatherine E Hanlon, Alysia N Lozano-Ondoua, Puja J Umaretiya, et al.
Blood|June 2, 2012
FANCL ubiquitinates β-catenin and enhances its nuclear functionKim-Hien T Dao, Michael D Rotelli, Curtis L Petersen, et al.
Plos Genetics|October 2, 2010
Analysis of the Basidiomycete Coprinopsis cinerea reveals conservation of the core meiotic expression program over half a billion years of evolutionClaire Burns, Jason E Stajich, Andreas Rechtsteiner, et al.
Brain Research|May 10, 2011
Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic painKatherine E Hanlon, Dave S Herman, Richard S Agnes, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 18, 2013
Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effectsT M Largent-Milnes, S W Brookshire, D P Skinner, et al.
Journal of Patient-Reported Outcomes|July 18, 2019
Patient reported outcomes can improve performance status assessment: a pilot studyJoan E Broderick, Marcella May, Joseph E Schwartz, et al.
JCO Clinical Cancer Informatics|June 30, 2020
Quantified Kinematics to Evaluate Patient Chemotherapy Risks in ClinicZaki Hasnain, Tanachat Nilanon, Ming Li, et al.
Research Evaluation|May 9, 2014
Measuring the evolution and output of cross-disciplinary collaborations within the NCI Physical Sciences-Oncology Centers NetworkJodi E Basner, Katrina I Theisz, Unni S Jensen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 21, 2012
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonistsAlysia N Lozano-Ondoua, Katherine E Hanlon, Ashley M Symons-Liguori, et al.
JCO Clinical Cancer Informatics|September 24, 2020
Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care EncountersTanachat Nilanon, Luciano P Nocera, Alexander S Martin, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Breast Cancer (Dove Medical Press)|May 18, 2016
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependentKatherine E Hanlon, Alysia N Lozano-Ondoua, Puja J Umaretiya, et al.
Blood|June 2, 2012
FANCL ubiquitinates β-catenin and enhances its nuclear functionKim-Hien T Dao, Michael D Rotelli, Curtis L Petersen, et al.
Plos Genetics|October 2, 2010
Analysis of the Basidiomycete Coprinopsis cinerea reveals conservation of the core meiotic expression program over half a billion years of evolutionClaire Burns, Jason E Stajich, Andreas Rechtsteiner, et al.
Brain Research|May 10, 2011
Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic painKatherine E Hanlon, Dave S Herman, Richard S Agnes, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 18, 2013
Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effectsT M Largent-Milnes, S W Brookshire, D P Skinner, et al.
Journal of Patient-Reported Outcomes|July 18, 2019
Patient reported outcomes can improve performance status assessment: a pilot studyJoan E Broderick, Marcella May, Joseph E Schwartz, et al.
JCO Clinical Cancer Informatics|June 30, 2020
Quantified Kinematics to Evaluate Patient Chemotherapy Risks in ClinicZaki Hasnain, Tanachat Nilanon, Ming Li, et al.
Research Evaluation|May 9, 2014
Measuring the evolution and output of cross-disciplinary collaborations within the NCI Physical Sciences-Oncology Centers NetworkJodi E Basner, Katrina I Theisz, Unni S Jensen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 21, 2012
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonistsAlysia N Lozano-Ondoua, Katherine E Hanlon, Ashley M Symons-Liguori, et al.
JCO Clinical Cancer Informatics|September 24, 2020
Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care EncountersTanachat Nilanon, Luciano P Nocera, Alexander S Martin, et al.
Pageof 12